Skip to main content

Peer Review reports

From: Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis

Original Submission
30 May 2024 Submitted Original manuscript
21 Jun 2024 Author responded Author comments - Rui Liu
Resubmission - Version 2
21 Jun 2024 Submitted Manuscript version 2
27 Jun 2024 Reviewed Reviewer Report
18 Nov 2024 Reviewed Reviewer Report
30 Nov 2024 Author responded Author comments - Rui Liu
Resubmission - Version 3
30 Nov 2024 Submitted Manuscript version 3
6 Dec 2024 Reviewed Reviewer Report
11 Dec 2024 Author responded Author comments - Rui Liu
Resubmission - Version 4
11 Dec 2024 Submitted Manuscript version 4
Publishing
2 Jan 2025 Editorially accepted
30 Jan 2025 Article published 10.1186/s12890-025-03479-2

You can find further information about peer review here.

Back to article page